Post Resch Tallon Group’s Cardlytics CDLX Stock Holding History

Post Resch Tallon Group’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,000	Closed	-$20K	–	139
2026 Q1	$20K	Hold	2,000	–	–	0.02%	118
2025 Q4	$23K	Hold	2,000	–	–	0.02%	109
2025 Q3	$48.6K	Hold	2,000	–	–	0.04%	108
2025 Q2	$32.9K	Buy	2,000 +1,000	+100%	+$17.3K	0.03%	100
2025 Q1	$17.9K	Hold	1,000	–	–	0.02%	100
2024 Q4	$37.3K	Buy	+1,000	New	+$38.3K	0.04%	102

Post Resch Tallon Group's CDLX Position: Q2 2026 in Review

Post Resch Tallon Group sold out of Cardlytics (CDLX) in Q2 2026, closing a stake of 2,000 shares — an estimated $20K sold.

Post Resch Tallon Group first reported a position in CDLX in Q4 2024 and held it in 6 quarters. The position peaked at $48.6K in Q3 2025. 0 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

Post Resch Tallon Group reported no remaining Cardlytics position as of Q2 2026 after selling out during the quarter.
Post Resch Tallon Group sold 2,000 Cardlytics shares in Q2 2026, an estimated $20K.
Post Resch Tallon Group first reported a position in Cardlytics in Q4 2024 and held it in 6 quarters.
Post Resch Tallon Group's Cardlytics position peaked at $48.6K in Q3 2025.
0 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on Post Resch Tallon Group's 13F filing for Q2 2026, filed 7 Jul 2026.